Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk - Wikidata - awgldk - TriplyDB

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

http://www.wikidata.org/entity/Q28943335

about

TERT gene harbors multiple variants associated with pancreatic cancer susceptibility Telomere structure and maintenance gene variants and risk of five cancer types The European Hematology Association Roadmap for European Hematology Research: a consensus document A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia Genome-wide association analysis of chronic lymphocytic leukaemia, Hodgkin lymphoma and multiple myeloma identifies pleiotropic risk loci Genome-wide association study identifies multiple risk loci for renal cell carcinoma.Search for rare protein altering variants influencing susceptibility to multiple myeloma Variants in ELL2 influencing immunoglobulin levels associate with multiple myeloma.Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients.Genetic factors influencing the risk of multiple myeloma bone disease Genome-wide association study identifies multiple susceptibility loci for multiple myeloma.A new GWAS and meta-analysis with 1000Genomes imputation identifies novel risk variants for colorectal cancer Single-molecule analysis reveals widespread structural variation in multiple myeloma.Implementation of genome-wide complex trait analysis to quantify the heritability in multiple myeloma.Low-frequency coding variants at 6p21.33 and 20q11.21 are associated with lung cancer risk in Chinese populations NCOA1 is a novel susceptibility gene for multiple myeloma in the Chinese population: A case-control study.Meta-analysis of genome-wide association studies identifies common susceptibility polymorphisms for colorectal and endometrial cancer near SH2B3 and TSHZ1.Family history of hematologic malignancies and risk of multiple myeloma: differences by race and clinical features Genome-wide association study identifies variation at 6q25.1 associated with survival in multiple myeloma.Multiple myeloma in the marrow: pathogenesis and treatments.Genome-wide association study of colorectal cancer in Hispanics.HLA polymorphism and risk of multiple myeloma.A common variant within the HNF1B gene is associated with overall survival of multiple myeloma patients: results from the IMMEnSE consortium and meta-analysis.A genome-wide association study yields five novel thyroid cancer risk loci.Common genetic variants in 11q13.3 and 9q22.33 are associated with molecular subgroups of multiple myeloma Loss of TRPV2 Homeostatic Control of Cell Proliferation Drives Tumor Progression Inherited genetic susceptibility to multiple myeloma.Genetics in myeloma: genetic technologies and their application to screening approaches in myeloma.The impact of methylation quantitative trait loci (mQTLs) on active smoking-related DNA methylation changes.Next-generation sequencing of a family with a high penetrance of monoclonal gammopathies for the identification of candidate risk alleles.Multiple myeloma and family history of lymphohaematopoietic cancers: Results from the International Multiple Myeloma Consortium.Genomewide association study on monoclonal gammopathy of unknown significance (MGUS).Genomic Aberrations in Multiple Myeloma.Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation.Genome-wide association study of immunoglobulin light chain amyloidosis in three patient cohorts: comparison with myeloma.Multiple myeloma risk variant at 7p15.3 creates an IRF4-binding site and interferes with CDCA7L expression Identification of miRSNPs associated with the risk of multiple myeloma.Diagnosis and classification of hematologic malignancies on the basis of genetics.Genetic Susceptibility to Bortezomib-Induced Peripheral Neuroropathy: Replication of the Reported Candidate Susceptibility Loci.Bortezomib-induced peripheral neuropathy: A genome-wide association study on multiple myeloma patients.

P2860

5601a16a0610eafc2a05b6eca7c33eb7ad63ec74 d70230c68650c9ee70de9fb63bdbc8fae1654178

P248

Q28386653-56AF4F86-436B-4D04-8084-407430C429A2 Q28397509-2B611028-FDB9-424F-9DAE-3F39EFBCD3CB Q28830861-59C031A5-11C4-441B-8E48-3F1D25212E69 Q28943318-4F9B4E4B-4A46-4169-A0C0-032D0AC19605 Q29248527-7CA6978E-7898-4445-AB7E-2F0AC5DB0DCD Q33804470-56EE9F42-F583-4B0C-A663-0125CD8A0CBC Q33829446-65FFC621-93D1-4D03-B253-5094DDD8E23B Q34669975-A42A870E-DF83-4425-A1A0-1021B6AB9631 Q34671809-317A1CE7-8B4A-4D38-8FC1-9AE6D9ECF12E Q34674841-85D8A748-4924-4987-B67D-FE87B16C1FBF Q34677689-72DB9C8D-F59C-4127-8503-B3C20BEE6CA7 Q35626744-0B8A5852-3B04-40B0-BD81-64F6D99FAE99 Q35796097-6E6F2539-5EB4-4708-A1F6-7898582F0BC7 Q35885086-AD2929C9-03AB-4A9A-8795-CF8AC950D26C Q36061600-ADA2D379-CB09-48DF-A3DE-E4C831432B23 Q36298356-C8FF88ED-5D99-4E6A-8DFA-5DED6E53A86E Q36333368-9EB60893-3341-4DED-ABB2-59CD5099EA1C Q36437403-F2F1D4B1-A581-4CB3-8FC6-AAF89BA8E340 Q36511162-D7CD1028-6963-4E87-ADE2-4EE83DD4C2FA Q36725401-8BBAA82F-4AA7-412E-A5B6-22F6DF27C442 Q36927009-A1651988-EE95-4541-B2AE-C953EA7E2F2E Q37468338-8ACBF3AB-937D-40C4-B22D-F53CA938A6B0 Q37644812-D63ADC2C-6B1A-444A-85D1-37C3CDDCE009 Q37652005-CA4E0D6A-B9EF-49B0-83A3-9E1C6AB98FFD Q37671719-2FC28412-1C9B-42FA-A3E5-BA8E98CC8C14 Q37693612-407C6A5F-D70A-42D6-B3A4-21B49FF6D216 Q38163845-43DB98B0-395D-470B-9EB7-0A486F2C7E57 Q38348173-4663E768-0725-4A7B-B633-4550649BFE97 Q38616634-FB4F7CDA-80AE-46C1-A7AB-27D6F118E29D Q38764731-427C3374-F413-49B8-888E-62A926B29744 Q38850007-E97D0749-E1D7-4F83-B789-1F762810DB4E Q38856161-1F5D844F-AFE8-49E2-897A-C004460716EC Q38970573-09321135-928D-416F-A0DD-CF89B66322CC Q39021977-15FE722D-94DA-40D8-B9C5-BFD62C3B9C94 Q39063150-70B96BE4-A871-4C96-9995-D16830F99BC0 Q39156834-76038CA4-63D9-4B7A-BBF6-08CD8DD004DA Q39309897-6C4F8466-22FA-4AB2-ABFD-9CC2983E1B35 Q39363409-23B1DF40-01CA-468E-A693-8A68EC8FD881 Q39597050-FEFBAE6C-3CC4-4A7A-980E-EFF222CE5903 Q40286050-BBAD6D63-27E7-4245-9EA8-3C429150F464

P2860

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

http://www.wikidata.org/entity/Q28943335

description

2013 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

articolo scientifico

@it

artículu científicu espublizáu en 2013

@ast

im Oktober 2013 veröffentlichter wissenschaftlicher Artikel

@de

scientific journal article

@en

wetenschappelijk artikel (gepubliceerd op 2013/10/01)

@nl

наукова стаття, опублікована в жовтні 2013

@uk

مقالة علمية (نشرت في أكتوبر 2013)

@ar

name

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

@ast

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

@en

type

label

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

@ast

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

@en

prefLabel

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

@ast

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

@en

P1433

Q28943335-C75A8067-71DF-4873-9694-FCB78471456E

P1476

Q28943335-C2CDF5A4-6A3D-41E0-9434-58267B30D214

P2093

Q28943335-23B82A2A-1CE5-4698-A6A8-4359C694336A

Q28943335-30A28BD8-9EB8-48C5-AA21-701F9CC351AE

Q28943335-3BBF263B-CE57-4F02-A3B9-1657E4126430

Q28943335-44864B50-012C-428C-ADC2-7EFAA99C6487

Q28943335-49A42A49-8ABE-4C7A-B3D3-29722AB648B7

Q28943335-5153AFE7-AD91-40DB-9385-42B7F684B079

Q28943335-577B6960-A641-4595-ACA3-026D98D53119

Q28943335-593403B7-BF07-4308-A98C-08782124226B

Q28943335-59E93963-F6F9-4291-B07C-D669C7B1C9DC

Q28943335-5E5B6BAD-FDA1-45E7-B43E-306FD167EDA7

P2860

Q28943335-022B33B7-9125-4A87-A83C-C7E5441A31D2

Q28943335-0E0DAF1C-F3D3-4A50-980C-1B5895894154

Q28943335-11713194-FA4D-4CF5-806F-1D5C853B750F

Q28943335-15599B56-B6CB-4530-A2A6-6C9EC32319FC

Q28943335-1579AB38-828E-43EB-AA53-5AF154403EF1

Q28943335-15CEA3BE-6A03-45A4-A5B3-255BD5AD475B

Q28943335-18E4B3D4-F361-43AA-9565-4A82E4AC0FD1

Q28943335-1DA51D43-98C2-4F69-819B-3277745036BC

Q28943335-29495218-934A-4AD4-8841-AC3A2FBDB312

Q28943335-2F00CB10-1969-40E8-83BA-430C455A020E

P2888

Q28943335-14D085B0-C122-4670-B572-D71CEEA42EFC

P304

Q28943335-55CAFE0D-BFB1-472C-A6D2-43CE4675186C

P31

Q28943335-69E6660A-8ADF-4077-86E6-B9B60B598605

P3181

Q28943335-F039282E-F524-4669-8DCC-CADC3A165C3C

P356

Q28943335-D0898ECA-C375-4DD5-99AC-CDAB11477344

P407

Q28943335-DD1AC2CB-2378-4FF5-9C09-71F01CDF5F87

P433

Q28943335-0D983DED-490D-4E10-B9F1-20972DA1D0BC

P478

Q28943335-FB88D3AA-1566-407A-A856-5CEE4C9583E4

P50

Q28943335-47EA51D9-45C5-44E0-A455-C8C238F85B77

Q28943335-7744F182-84B5-426F-B39E-0EF93D3F6BB2

Q28943335-951B218E-05FB-4D3C-897D-EAA3A85C5711

Q28943335-B3C103E3-F6D4-411F-9546-500AEF8B37E4

Q28943335-C17B0EE7-D6BC-4657-A75B-A1207CFDD9C2

Q28943335-C2DF3768-2938-42A1-AB0C-1D3C062B7F5C

Q28943335-D7C42D4E-EF12-441D-BECB-13A341B2A93A

Q28943335-E1244A83-4C1B-4807-A162-EFC7B610B164

Q28943335-EC28C710-B15A-4D6B-B101-3E3E748051D6

P577

Q28943335-B8091E1B-93C1-49F9-B01D-2C22F7C40162

P698

Q28943335-03D12084-E927-4E17-AAD2-FB5294E1A360

P932

Q28943335-4FE870F9-CD53-4643-A861-61331EE792B8

P3181

P356

P1433

Nature Genetics

P1476

Common variation at 3q26.2, 6p21.33, 17p11.2 and 22q13.1 influences multiple myeloma risk

@en

P2093

Amy Holroyd

http://www.w3.org/2001/XMLSchema#string

Anna Jauch

http://www.w3.org/2001/XMLSchema#string

Bowang Chen

http://www.w3.org/2001/XMLSchema#string

Chris Fegan

http://www.w3.org/2001/XMLSchema#string

Christian Langer

http://www.w3.org/2001/XMLSchema#string

Christian Straka

http://www.w3.org/2001/XMLSchema#string

Daniel Chubb

http://www.w3.org/2001/XMLSchema#string

David C. Johnson

http://www.w3.org/2001/XMLSchema#string

Elisabeth Dörner

http://www.w3.org/2001/XMLSchema#string

Faith E. Davies

http://www.w3.org/2001/XMLSchema#string

P2860

Genome-wide associations of gene expression variation in humans

The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature

PLINK: a tool set for whole-genome association and population-based linkage analyses

The structure of haplotype blocks in the human genome

Quantifying heterogeneity in a meta-analysis

Principal components analysis corrects for stratification in genome-wide association studies

The CCND1 c.870G>A polymorphism is a risk factor for t(11;14)(q13;q32) multiple myeloma

Common variation at 3p22.1 and 7p15.3 influences multiple myeloma risk

A genome-wide association study of Hodgkin's lymphoma identifies new susceptibility loci at 2p16.1 (REL), 8q24.21 and 10p14 (GATA3)

Meta-analysis of three genome-wide association studies identifies susceptibility loci for colorectal cancer at 1q41, 3q26.2, 12q13.13 and 20q13.33

P2888

P304

1221–1225

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

319060

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/NG.2733

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P50

Hermann Einsele

Hartmut Goldschmidt

Markus M Nöthen

Peter Broderick

Brian A. Walker

Gareth J Morgan

P577

2013-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23955597

http://www.w3.org/2001/XMLSchema#string

P932

5053356

http://www.w3.org/2001/XMLSchema#string